A graduate of Nankai University, Dr. Hong Chen completed her Ph.D. and postdoctoral training at the Yale University School of Medicine in the laboratory of Dr. Pietro De Camilli, where she discovered a family of endocytic adaptor proteins called epsins. Dr. Chen worked in the Cardiovascular Biology Research Program at the University of Oklahoma Health Sciences Center before moving to Boston Children's Hospital and Harvard Medical School in 2015.

Her group continues to study epsins and other endocytic adaptors for their impact on disease initiation and progression. Dr. Chen received the Irvine H. Page Young Investigator Research Award from the American Heart Association (AHA) in 2013 and the AHA Established Investigator Award in 2015. She is currently serving on the AHA Arteriosclerosis, Thrombosis, and Vascular Biology Woman’s Leadership Committee and serves as a grant reviewer for the AHA and the National Institutes of Health (NIH).

Dr. Chen is always seeking highly-motivated graduate students, post-doctoral fellows, and research scientists with a strong interest in studying molecular and cellular biology. Candidates should have a strong background in one or more of the following areas: mouse genetics, cardiovascular biology, immunology, metabolic regulation, signal transduction, bioinformatics, rodent surgery, and mammalian physiology. Researchers are expected to have a strong work ethic, excellent organizational and communication skills, as well as an ability to think critically and independently.

Dr. Chen is affiliated with Boston Children's Hospital and Harvard Medical School, which are preeminent medical research institutions located in the Longwood Medical Area of Boston. These institutions offer a highly-varied academic and cultural environment in which to work. Inquiries about potentialy positions should include a cover letter, curriculum vitae, and three references.